Nanomedicine and Onco-Immunotherapy: From the Bench to Bedside to Biomarkers

The broad relationship between the immune system and cancer is opening a new hallmark to explore for nanomedicine. Here, all the common and synergy points between both areas are reviewed and described, and the recent approaches which show the progress from the bench to the beside to biomarkers devel...

Full description

Saved in:
Bibliographic Details
Published in:Nanomaterials (Basel, Switzerland) Switzerland), 2020-06, Vol.10 (7), p.1274
Main Authors: Acebes-Fernández, Vanessa, Landeira-Viñuela, Alicia, Juanes-Velasco, Pablo, Hernández, Angela-Patricia, Otazo-Perez, Andrea, Manzano-Román, Raúl, Gongora, Rafael, Fuentes, Manuel
Format: Article
Language:English
Subjects:
immune-checkpoint inhibitors
immunogenic cell death
immunotherapy
nanomaterials
nanomedicine
oncotherapy
Review
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The broad relationship between the immune system and cancer is opening a new hallmark to explore for nanomedicine. Here, all the common and synergy points between both areas are reviewed and described, and the recent approaches which show the progress from the bench to the beside to biomarkers developed in nanomedicine and onco-immunotherapy.
ISSN:2079-4991
2079-4991
DOI:10.3390/nano10071274